000 01674 a2200445 4500
005 20250512002112.0
264 0 _c19880620
008 198806s 0 0 eng d
022 _a0090-8258
024 7 _a10.1016/0090-8258(88)90038-8
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aWeiner, S A
245 0 0 _aA phase II trial of mitomycin, vincristine, bleomycin, and cisplatin (MOBP) as neoadjuvant therapy in high-risk cervical carcinoma.
_h[electronic resource]
260 _bGynecologic oncology
_cMay 1988
300 _a1-6 p.
_bdigital
500 _aPublication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
650 0 4 _aAdenocarcinoma
_xdrug therapy
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aAntineoplastic Combined Chemotherapy Protocols
_xtherapeutic use
650 0 4 _aBleomycin
_xadministration & dosage
650 0 4 _aCarcinoma, Squamous Cell
_xdrug therapy
650 0 4 _aCisplatin
_xadministration & dosage
650 0 4 _aClinical Trials as Topic
650 0 4 _aCombined Modality Therapy
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aMiddle Aged
650 0 4 _aMitomycin
650 0 4 _aMitomycins
_xadministration & dosage
650 0 4 _aNeoplasm Staging
650 0 4 _aUterine Cervical Neoplasms
_xdrug therapy
650 0 4 _aVincristine
_xadministration & dosage
700 1 _aAristizabal, S
700 1 _aAlberts, D S
700 1 _aSurwit, E A
700 1 _aDeatherage-Deuser, K
773 0 _tGynecologic oncology
_gvol. 30
_gno. 1
_gp. 1-6
856 4 0 _uhttps://doi.org/10.1016/0090-8258(88)90038-8
_zAvailable from publisher's website
999 _c2458800
_d2458800